Overview


Antibody pair kits, also known as matched antibody or antibody sandwich pairs, are reagent sets used in immunoassays, particularly in enzyme-linked immunosorbent assays (ELISAs). These kits are designed to detect and quantify specific proteins or antigens in a sample. This kit includes a titrated capture, biotinylated detector antibody pair, and calibrated protein standard. They are available in two sizes, with enough reagents for either 5 or 10 x 96-well plates using a standard sandwich ELISA. These antibody pair kits are highly valuable for research and diagnostics purposes as they allow for the precise and sensitive detection of target proteins in a complex mixture. They are especially useful in cases where precise quantification is necessary, such as in medical diagnostics, drug development, and biological research. 

Streptavidin-HRP conjugate antibody pair kits are a specific type of antibody pair kit. Streptavidin is a tetrameric protein derived from Streptomyces sp. that exhibits an extremely strong binding affinity to the vitamin biotin, with a dissociation constant (Kd) of approx~ 10-14 mol/l. The high-affinity recognition of biotin and biotinylated molecules has elevated streptavidin, one of the most important components in diagnostics and laboratory kits. In this kit, streptavidin is conjugated to HRP, an enzyme that can produce a detectable signal and allow for a strong and specific binding. This method is widely used in various immunoassays and molecular biology techniques for its high specificity and sensitivity.

FutureWise Market Research has published a report that provides an insightful analysis antibody pair kits market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, antibody pair kits market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Abcam plc.
  • Abnova Corporation
  • Thermo Fisher Scientific
  • Bosterbio
  • Novus Biologicals
  • Tonbo Biosciences
  • Creative Diagnostics
  • Bio-Rad Laboratories, Inc.
  • GeneTex, Inc.
  • Arigo biolaboratories Corp.
  • RayBiotech Life

(Note: The list of the major players will be updated with the latest market scenario and trends)

The increasing prevalence of advancements in biotechnology and life sciences is driving the development of antibody pair kits, potentially leading to a new era of advanced and highly efficient diagnostic tools. This demand for technological advancement has created antibody pairs with enhanced specificity, sensitivity, and adaptability, allowing clinicians and researchers to conduct more accurate and reliable trials and diagnostics. Thus, the growing interest and adoption of these cutting-edge antibody pair kits among healthcare professionals are further propelling the market growth. Also, as healthcare requirements continue to increase, there's a rising demand for precise and reliable diagnostic tests that may also play a vital role in various diagnostic applications, hence contributing to the market growth. However, factors such as low expression of target antigens, which limit the efficacy of these kits, immune responses to the antibodies, and physical barriers preventing antibody binding may restrain the market growth. Moreover, developing and advancing antibody pair kits demand significant investments in R&D. This financial commitment may present a barrier, especially for smaller firms or institutions with limited resources. The high costs associated with R&D efforts may hinder their ability to enter or compete in the market. Thus potentially restraining the growth of the antibody pair kits market over the projection period.

By Product Type

  • Capture antibody pair kits
  • Calibrated standard antibody pair kits
  • Detection biotinylated antibody pair kits
  • Streptavidin-hrp conjugate antibody pair kits
  • Buffers

By End User

  • Hospitals
  • Research Institutes
  • Diagnostics Laboratories
  • Speciality Clinics

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest revenue share in the market in 2022. This is attributable to factors such as the rise in chronic diseases, the development of effective strategies, the emergence of innovative standards in expansion to novel businesses, continuous technological advancements, a well-developed healthcare system, growing environmental awareness, and the rising need for streamlined processes in the region. In addition, the presence of a number of biotech and pharmaceutical companies, substantial investment in healthcare R&D, product innovation, and strategic collaborations further contribute significantly to the target market growth during the forecast period in the area.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Antibody Pair Kits Market By Product Type, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Antibody Pair Kits Market Variables, Trends & Scope
    •         1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Antibody Pair Kits Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Antibody Pair Kits Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Antibody Pair Kits Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Capture antibody pair kits
        2. Calibrated standard antibody pair kits
        3. Detection biotinylated antibody pair kits
        4. Streptavidin-hrp conjugate antibody pair kits
        5. Buffers

  • 8.   Antibody Pair Kits Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Research Institutes
        3. Diagnostics Laboratories
        4. Speciality Clinics

  • 9.   North America Antibody Pair Kits Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Antibody Pair Kits Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Antibody Pair Kits Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Antibody Pair Kits Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abcam plc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abnova Corporation
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Thermo Fisher Scientific
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Bosterbio
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Novus Biologicals
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Tonbo Biosciences
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Creative Diagnostics
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Bio-Rad Laboratories, Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. GeneTex, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Arigo biolaboratories Corp.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. RayBiotech Life
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients